A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 1, 2008, Pages 86-90

  Nagai, Yoshiko ^a   Itabashi, Mitsuyo ^a   Mizutani, Mayuko ^a   Ogawa, Tetsuya ^a   Yumura, Wako ^a   Tsuchiya, Ken ^a   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Alkalosis; Citrate; Plasmapheresis; Respiratory alkalosis; Thrombotic thrombocytopenic purpura

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFOZOPRAN; CYCLOPHOSPHAMIDE; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; MEROPENEM; METHYLPREDNISOLONE; MIDAZOLAM; PREDNISOLONE; SEDATIVE AGENT; STEROID; VANCOMYCIN; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG ERUPTION; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; HEMOLYTIC ANEMIA; HOSPITAL ADMISSION; HUMAN; INFECTION; LABORATORY TEST; MENINGITIS; METABOLIC ALKALOSIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; RETICULOCYTE COUNT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALKALOSIS; ANTICOAGULANTS; CITRIC ACID; CYCLOPHOSPHAMIDE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VINCRISTINE;

EID: 38849104306     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00547.x     Document Type: Article

References (13)

1. McCarthy LJ, Dlott JS, Orazi A, Waxman D, Miraglia CC, Danielson CF. Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow. Ther Apher Dial 2004 5 : 80 6.
2. von Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002 6 : 320 8.
3. Bosch T, Wendler T. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review. Ther Apher 2001 5 : 182 5.
4. Yeo FE, Bohen EM, Yuan CM, Sawyers ES, Abbott KC. Therapeutic plasma exchange as a nephrological procedure: a single-center experience. J Clin Apher 2005 20 : 208 16.
5. Puig L, Mazzara R, Torras A, Castillo R. Adverse effects secondary to the treatment with plasma exchange. Int J Artif Organs 1985 8 : 155 8.
6. Bsic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 2005 9 : 391 5.
7. Marques MB, Huang ST. Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange. J Clin Apheresis 2001 16 : 120 4.
8. Furlan M, Lammle B. von Willebrand factor in thrombotic thrombocytopenic purpura. Thromb Haemost 1999 82 : 592 600.
9. Moake JL. Thrombotic thrombocytopenic purpura: the systemic clumping 'plague'. Annu Rev Med 2002 53 : 75 88.
10. Marques MB, Mayfield CA, Blackall DP. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma. Am J Clin Pathol 2004 121 (Suppl. S89 96.
11. Pearl RG, Rosenthal MH. Metabolic alkalosis due to plasmapheresis. Am J Med 1985 79 : 391 3.
12. Korosi A, Kahn T, Kalb T, Uribarri J. Marked hyperlactatemia associated with severe alkalemia in a patient with thrombotic thrombocytopenic purpura. Am J Kid Dis 2000 36 : E6.
13. Buturovic-Ponikvar J, Pernat AM, Ponikvar R. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin free hemodialysis helps to attenuate citrate load. Ther Apher Dial 2005 9 : 258 61.